Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,346.00
Bid: 11,850.00
Ask: 12,470.00
Change: 0.00 (0.00%)
Spread: 620.00 (5.232%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,346.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Grafton After Warning

Thu, 17th Oct 2019 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

GOLDMAN CUTS ROLLS-ROYCE PRICE TARGET TO 1196 (1232) PENCE - 'CONVICTION BUY'

----------

INVESTEC RAISES AVIVA TO 'BUY' ('ADD') - TARGET 455 (385) PENCE

----------

BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 1241 (1155) P - 'OVERWEIGHT'

----------

CS RAISES NATIONAL GRID TO 'OUTPERFORM' (NEUTRAL) - PRICE TARGET 970 (810) PENCE

----------

HSBC RAISES ASTRAZENECA PRICE TARGET TO 6235 (5180) PENCE - 'REDUCE'

----------

JEFFERIES CUTS ROYAL DUTCH SHELL PRICE TARGET TO 2780 (2900) PENCE - 'BUY'

----------

JEFFERIES CUTS BP PRICE TARGET TO 590 (625) PENCE - 'BUY'

----------

GOLDMAN CUTS ANGLO AMERICAN TARGET TO 2300 (2450) PENCE - 'CONVICTION BUY LIST'

----------

GOLDMAN CUTS GLENCORE PRICE TARGET TO 210 (220) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS RIO TINTO PRICE TARGET TO 5100 (5250) PENCE - 'BUY'

----------

GOLDMAN CUTS BHP GROUP PRICE TARGET TO 1900 (2100) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES ANTOFAGASTA PRICE TARGET TO 950 (850) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS ANTOFAGASTA PRICE TARGET TO 750 (810) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS BURBERRY GROUP PRICE TARGET TO 1950 (2000) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

PEEL HUNT CUTS GRAFTON GROUP TO 'HOLD' ('ADD') - TARGET 800 (860) PENCE

----------

JEFFERIES CUTS BELLWAY TO 'HOLD' ('BUY') - TARGET 3743 (3875) PENCE

----------

UBS CUTS WEIR GROUP TO 'NEUTRAL' ('BUY') - TARGET 1450 (1550) PENCE

----------

HSBC CUTS WEIR GROUP PRICE TARGET TO 1820 (1870) PENCE - 'BUY'

----------

RBC CUTS RATHBONE BROTHERS PRICE TARGET TO 2450 (2500) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES LANCASHIRE HOLDINGS PRICE TARGET TO 775 (750) PENCE - 'OUTPERFORM'

----------

BERENBERG CUTS CENTAMIN PRICE TARGET TO 113 (120) PENCE - 'HOLD'

----------

HSBC RAISES WIZZ AIR PRICE TARGET TO 3250 (3100) PENCE - 'HOLD'

----------

HSBC RAISES EASYJET PRICE TARGET TO 1450 (1300) PENCE - 'BUY'

----------

BERENBERG RAISES IBSTOCK PRICE TARGET TO 310 (300) PENCE - 'BUY'

----------

GOLDMAN CUTS KAZ MINERALS TO 'NEUTRAL' ('BUY') - TARGET 475 (675) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG RAISES ASOS PRICE TARGET TO 3000 (2500) PENCE - 'HOLD'

----------

BERENBERG RAISES FORTERRA PRICE TARGET TO 310 (290) PENCE - 'HOLD'

----------

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
24 Oct 2023 17:08

LONDON MARKET CLOSE: FTSE 100 shakes off midday losses after US data

(Alliance News) - The FTSE 100 closed in the green on Tuesday following positive private sector data out of the US, despite figures closer to home showing a weaker UK private sector and rising unemployment.

Read more
24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

Read more
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.